Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Hui Chen

Associate Professor of Medicine
Medicine, Medical Oncology

Current Appointments & Affiliations


Associate Professor of Medicine · 2022 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2023 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting.

Journal Article J Hematol Oncol · August 26, 2024 Multiple classes of therapies targeting claudin-18 isoform 2 (CLDN18.2) are under development for the treatment of advanced gastroesophageal adenocarcinoma and other solid tumors. At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, the ... Full text Link to item Cite

Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting.

Journal Article J Hematol Oncol · March 3, 2023 Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hematology (ASH) annual meeting. Encouraging efficacy data were presented from first-in-human studies of two investigati ... Full text Link to item Cite

Quantification of IGF-1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis.

Journal Article Eur J Haematol · December 2019 BACKGROUND: To make a definite diagnosis of essential thrombocytosis (ET) from reactive thrombocytosis (RT), the most reliable criteria are the presence of driver mutations, namely JAK2, CALR, or MPL gene mutations. In the absence of these driver mutations ... Full text Link to item Cite
View All Publications